These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. New intralesional therapy for basal cell carcinoma by 2% zinc sulphate solution. Sharquie KE, Al-Nuaimy AA, Al-Shimary FA. Saudi Med J; 2005 Feb; 26(2):359-61. PubMed ID: 15770334 [No Abstract] [Full Text] [Related]
28. Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod. Latour I, Hernández-Martín A, Ged C, Knöpfel N, Taïeb A, Torrelo A. J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e282-e284. PubMed ID: 29377344 [No Abstract] [Full Text] [Related]
30. Intralesional Bleomycin as an Adjunct Therapeutic Modality in Eyelid and Extraocular Malignancies and Tumors. Meyer D, Gooding C. Middle East Afr J Ophthalmol; 2015 Jul; 22(4):410-4. PubMed ID: 26692709 [Abstract] [Full Text] [Related]
31. Periocular basal cell carcinoma pathological reporting. Sun MT, Wu A, Huilgol SC, Selva D. Br J Ophthalmol; 2013 Dec; 97(12):1612-3. PubMed ID: 24123910 [No Abstract] [Full Text] [Related]